Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
Attention New Investors!
Don’t listen to a word that Sangijuelas1 spouts. He is a paid de-ramper who spends all his time bashing Tiziana, and cleverly twists the truth to put the company in a bad light!!!
I have read some of the Tiziana patents and speaking as someone who has researched and written a few patents myself I can speak with some knowledge on this matter. Firstly the patents I have read are in regard to the formulation of the mAbs, not the dosing mechanism per se. That is to say they have patented the use of nano-particle formulations. Secondly, and most importantly, the patents are carefully worded to cover both Foralumab AND other mAbs! Thirdly, I was on the recent investor call it was said that Tiziana are currently in discussions with large pharma on royalty based agreements for the use of these dosing ‘formulations’ for other mAbs! It sounded like final sign-off was just waiting on the next set of results - in March NOT MAY! You lying…
Begone Sangijuelas1! Go and get yourself an alternative occupation that you can actually be proud of, instead of helping investors lose money and possibly destroy the chances for medical science to save lives and relieve suffering! How can you honestly be proud of what you and others like you do? Hey?
Regards to all LTH.
It’s the
London Scam Exchange
it really is!
Regards all LTH.
Over the last few months I have nervously sold down and bought back and managed to lower my average price now by 33%. I hate to say it but de-rampers can have their uses at times.
Regards to all LTH.
:)
…but they will all need to get away from using infusion for dosing due to the ridiculously high toxicity! (and are health services spending a lot of money creating expensive new infusion centres just for Covid patients away from cancer patients? I think not!)
Therefore, without spending a lot of time and money coming up with their own unique platform, they will have to use one of the 3 mAbs dosing methods that TILS already hold the patents for:
Inhalation, nasal or oral.
TILS are in a VERY powerful position.
Regards to all LTH.
I couldn’t agree more rp6577!
Fill your boots!
:)
Hi,
I agree totally, the utter Corruption on the LSE has gone too far IMO. I for one am trying to concentrate on more shares in other countries, and other types of investments, although that didn’t stop me topping up my TILS holdings at fantastic prices these last few days.
Good riddance to all the fake posters here, I can’t wait to be rid of all your manipulation and utter tripe and underhand tactics!
Regards to all LTH.
@StarKnight
>>
are they ever going to complete a trial? let alone a successful one!
SO HOW ARE THEY BEING ALLOWED TO RUN PHASE 2 TRIALS IF THEY DIDN’T SUCCESSFULLY COMPLETE PHASE 1 TRIALS ???
+
HOW ARE YOU CLAIMING THAT AN 86% FOLLOWED BY A SECOND 85% TRIAL RESULT OF REDUCTION IN LUNG DAMAGE, FOR FORALUMAB, IS NOT SUCCESSFUL ???
IMO a takeover or something can’t be too far away due to the level of deramping taking place now.
Regards to all LTH.
@Bluebelly
LOL!
:)))
IMO Mr. Market has over the years turned into a lying, cheating scam run by corrupt middle-men to steal money from private investors. The good news is that once all the markets have been block-chained, and we have near instant settlements, most of the MM’s will be out of business, hooray for that day it can’t come soon enough!!!
This board is overrun with manipulators, but hardened PI’s like myself who have done the research KNOW THE VALUE OF WHAT WE HOLD, despite all the constant tweets to the opposite. Begone, all ye time wasters! It takes years for the roots of a bamboo tree to be created, the BOD are carefully cultivating those roots and one day this will be the fastest growing plant in this insect infested jungle. Mr. Market needs a clear-out, it’s sunk into the swamp!
Regards to all LTH.
Hi,
It looked to me like Sang just tried to get people to buy on the spike. I wouldn’t trust him with a barge pole tbh! Don’t listen to him.
Regards,
…in dedication:
These tiny phone keyboards… argh.
We should adopt Optimus Prime as the TILS mascot, with the following quotes:
“In any war, there are calms between storms. There will be days when we lose faith. Days when our allies turn against us...but the day will never come that we forsake this planet and its people.”
“We will defend humanity. We will defend… our home.“
In desication:
To the millions of lost loved ones, and all the sick people on our planet who SO BADLY need the power of Foralumab!
(Serious undertones intentional.)
Regards,
I just noticed that the year scale share price chart inverted TILS man has transformed into the outline of the one and only:
Optimus Prime!
(from the Transformers movie)
That’s not just bullish, that’s Epically bullish!
LOL
:)))
Hi Folks,
This could be the last chance to buy at this super cheap entry point. Fill your boots!
Regards,
@ROCK
Absolutely! and the BOD continue to notch up more and more amazing results that continue to prove that their theory and their dosing platform works as designed.
For sure there will be NDAs in the pipeline soon if not already underway, with Regeneron surely being one of the main companies in the background following the recruitment of their CMO to TILS. Does anyone have any other possible contenders for a joint venture or a takeover bid?
The BOD will have the final evidence they need from the MS nasal Foralumab brain scan results in 3-4 months. Firework show after that!
Regards,
Eyes on the Prize folks! Eyes on the Prize!
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
$125 Billion, $125 Billion, $125 Billion,
…
:)))
LOL
He’s a scientist not a business man, you are asking the wrong person, but basically he said he doesn’t know when Accustem will be listed, several times. I do believe it’s entirely out of their hands, and they are not going to give an estimated date ever again considering the uproar that has been going on with missed dates.
Targeting a $125 billion market with an already much de-risked Foralumab plus patented dosing platform will hopefully help focus investor minds on this BB.
That’s one heck of a prize at the end!
:)))
Regards,
Hi All,
Luckily I just managed to ask Dr. S. on that US Zoom call when we would get results from the CT scans for the MS nasal Foralumab trial! However the answer was a minimum of 3-4 months. Not the answer I was expecting as I asked for ‘initial’ scan results. Oh well.
The better answer was for my second question about if there are more patents in the pipeline, for which the answer was yes: two, but you will all have to watch a recording as I didn’t catch what the patents were for. LOL
Regards,
Many thanks for posting that. I caught the end and managed to get two questions answered. Fab!
If anyone has a link to the recording that would help others who missed some or all of it.
Regards,